Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Primers
1.2.3 Probes
1.2.4 Intermediate-scale Synthesis Oligos
1.2.5 Large-scale Synthesis Oligos
1.2.6 Linkers and Adaptors
1.3 Market by Application
1.3.1 Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Commercial
1.3.3 Academic Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Solid-phase Oligonucleotide Synthesis Market Perspective (2018-2033)
2.2 Global Solid-phase Oligonucleotide Synthesis Growth Trends by Region
2.2.1 Solid-phase Oligonucleotide Synthesis Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Solid-phase Oligonucleotide Synthesis Historic Market Size by Region (2018-2023)
2.2.3 Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Region (2024-2033)
2.3 Solid-phase Oligonucleotide Synthesis Market Dynamics
2.3.1 Solid-phase Oligonucleotide Synthesis Industry Trends
2.3.2 Solid-phase Oligonucleotide Synthesis Market Drivers
2.3.3 Solid-phase Oligonucleotide Synthesis Market Challenges
2.3.4 Solid-phase Oligonucleotide Synthesis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Solid-phase Oligonucleotide Synthesis by Players
3.1.1 Global Solid-phase Oligonucleotide Synthesis Revenue by Players (2018-2023)
3.1.2 Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Players (2018-2023)
3.2 Global Solid-phase Oligonucleotide Synthesis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Solid-phase Oligonucleotide Synthesis, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Solid-phase Oligonucleotide Synthesis Market Concentration Ratio
3.4.1 Global Solid-phase Oligonucleotide Synthesis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Solid-phase Oligonucleotide Synthesis Revenue in 2022
3.5 Global Key Players of Solid-phase Oligonucleotide Synthesis Head office and Area Served
3.6 Global Key Players of Solid-phase Oligonucleotide Synthesis, Product and Application
3.7 Global Key Players of Solid-phase Oligonucleotide Synthesis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Solid-phase Oligonucleotide Synthesis Breakdown Data by Type
4.1 Global Solid-phase Oligonucleotide Synthesis Historic Market Size by Type (2018-2023)
4.2 Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Type (2024-2033)
5 Solid-phase Oligonucleotide Synthesis Breakdown Data by Application
5.1 Global Solid-phase Oligonucleotide Synthesis Historic Market Size by Application (2018-2023)
5.2 Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Solid-phase Oligonucleotide Synthesis Market Size (2018-2033)
6.2 North America Solid-phase Oligonucleotide Synthesis Market Size by Type
6.2.1 North America Solid-phase Oligonucleotide Synthesis Market Size by Type (2018-2023)
6.2.2 North America Solid-phase Oligonucleotide Synthesis Market Size by Type (2024-2033)
6.2.3 North America Solid-phase Oligonucleotide Synthesis Market Share by Type (2018-2033)
6.3 North America Solid-phase Oligonucleotide Synthesis Market Size by Application
6.3.1 North America Solid-phase Oligonucleotide Synthesis Market Size by Application (2018-2023)
6.3.2 North America Solid-phase Oligonucleotide Synthesis Market Size by Application (2024-2033)
6.3.3 North America Solid-phase Oligonucleotide Synthesis Market Share by Application (2018-2033)
6.4 North America Solid-phase Oligonucleotide Synthesis Market Size by Country
6.4.1 North America Solid-phase Oligonucleotide Synthesis Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2018-2023)
6.4.3 North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Solid-phase Oligonucleotide Synthesis Market Size (2018-2033)
7.2 Europe Solid-phase Oligonucleotide Synthesis Market Size by Type
7.2.1 Europe Solid-phase Oligonucleotide Synthesis Market Size by Type (2018-2023)
7.2.2 Europe Solid-phase Oligonucleotide Synthesis Market Size by Type (2024-2033)
7.2.3 Europe Solid-phase Oligonucleotide Synthesis Market Share by Type (2018-2033)
7.3 Europe Solid-phase Oligonucleotide Synthesis Market Size by Application
7.3.1 Europe Solid-phase Oligonucleotide Synthesis Market Size by Application (2018-2023)
7.3.2 Europe Solid-phase Oligonucleotide Synthesis Market Size by Application (2024-2033)
7.3.3 Europe Solid-phase Oligonucleotide Synthesis Market Share by Application (2018-2033)
7.4 Europe Solid-phase Oligonucleotide Synthesis Market Size by Country
7.4.1 Europe Solid-phase Oligonucleotide Synthesis Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2018-2023)
7.4.3 Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Solid-phase Oligonucleotide Synthesis Market Size (2018-2033)
8.2 China Solid-phase Oligonucleotide Synthesis Market Size by Type
8.2.1 China Solid-phase Oligonucleotide Synthesis Market Size by Type (2018-2023)
8.2.2 China Solid-phase Oligonucleotide Synthesis Market Size by Type (2024-2033)
8.2.3 China Solid-phase Oligonucleotide Synthesis Market Share by Type (2018-2033)
8.3 China Solid-phase Oligonucleotide Synthesis Market Size by Application
8.3.1 China Solid-phase Oligonucleotide Synthesis Market Size by Application (2018-2023)
8.3.2 China Solid-phase Oligonucleotide Synthesis Market Size by Application (2024-2033)
8.3.3 China Solid-phase Oligonucleotide Synthesis Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Solid-phase Oligonucleotide Synthesis Market Size (2018-2033)
9.2 Asia Solid-phase Oligonucleotide Synthesis Market Size by Type
9.2.1 Asia Solid-phase Oligonucleotide Synthesis Market Size by Type (2018-2023)
9.2.2 Asia Solid-phase Oligonucleotide Synthesis Market Size by Type (2024-2033)
9.2.3 Asia Solid-phase Oligonucleotide Synthesis Market Share by Type (2018-2033)
9.3 Asia Solid-phase Oligonucleotide Synthesis Market Size by Application
9.3.1 Asia Solid-phase Oligonucleotide Synthesis Market Size by Application (2018-2023)
9.3.2 Asia Solid-phase Oligonucleotide Synthesis Market Size by Application (2024-2033)
9.3.3 Asia Solid-phase Oligonucleotide Synthesis Market Share by Application (2018-2033)
9.4 Asia Solid-phase Oligonucleotide Synthesis Market Size by Region
9.4.1 Asia Solid-phase Oligonucleotide Synthesis Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Solid-phase Oligonucleotide Synthesis Market Size by Region (2018-2023)
9.4.3 Asia Solid-phase Oligonucleotide Synthesis Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Type
10.2.1 Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Application
10.3.1 Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country
10.4.1 Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Genescript
11.1.1 Genescript Company Details
11.1.2 Genescript Business Overview
11.1.3 Genescript Solid-phase Oligonucleotide Synthesis Introduction
11.1.4 Genescript Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.1.5 Genescript Recent Developments
11.2 GeneArt (Thermofischer)
11.2.1 GeneArt (Thermofischer) Company Details
11.2.2 GeneArt (Thermofischer) Business Overview
11.2.3 GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Introduction
11.2.4 GeneArt (Thermofischer) Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.2.5 GeneArt (Thermofischer) Recent Developments
11.3 Renesas Electronics Corporation
11.3.1 Renesas Electronics Corporation Company Details
11.3.2 Renesas Electronics Corporation Business Overview
11.3.3 Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Introduction
11.3.4 Renesas Electronics Corporation Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.3.5 Renesas Electronics Corporation Recent Developments
11.4 DNA 2.0 (ATUM)
11.4.1 DNA 2.0 (ATUM) Company Details
11.4.2 DNA 2.0 (ATUM) Business Overview
11.4.3 DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Introduction
11.4.4 DNA 2.0 (ATUM) Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.4.5 DNA 2.0 (ATUM) Recent Developments
11.5 OriGene
11.5.1 OriGene Company Details
11.5.2 OriGene Business Overview
11.5.3 OriGene Solid-phase Oligonucleotide Synthesis Introduction
11.5.4 OriGene Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.5.5 OriGene Recent Developments
11.6 BBI
11.6.1 BBI Company Details
11.6.2 BBI Business Overview
11.6.3 BBI Solid-phase Oligonucleotide Synthesis Introduction
11.6.4 BBI Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.6.5 BBI Recent Developments
11.7 Genewiz
11.7.1 Genewiz Company Details
11.7.2 Genewiz Business Overview
11.7.3 Genewiz Solid-phase Oligonucleotide Synthesis Introduction
11.7.4 Genewiz Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.7.5 Genewiz Recent Developments
11.8 Eurofins Genomics
11.8.1 Eurofins Genomics Company Details
11.8.2 Eurofins Genomics Business Overview
11.8.3 Eurofins Genomics Solid-phase Oligonucleotide Synthesis Introduction
11.8.4 Eurofins Genomics Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.8.5 Eurofins Genomics Recent Developments
11.9 Gene Oracle
11.9.1 Gene Oracle Company Details
11.9.2 Gene Oracle Business Overview
11.9.3 Gene Oracle Solid-phase Oligonucleotide Synthesis Introduction
11.9.4 Gene Oracle Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.9.5 Gene Oracle Recent Developments
11.10 SBS Genetech
11.10.1 SBS Genetech Company Details
11.10.2 SBS Genetech Business Overview
11.10.3 SBS Genetech Solid-phase Oligonucleotide Synthesis Introduction
11.10.4 SBS Genetech Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.10.5 SBS Genetech Recent Developments
11.11 Bio Basic
11.11.1 Bio Basic Company Details
11.11.2 Bio Basic Business Overview
11.11.3 Bio Basic Solid-phase Oligonucleotide Synthesis Introduction
11.11.4 Bio Basic Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.11.5 Bio Basic Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Primers
Table 3. Key Players of Probes
Table 4. Key Players of Intermediate-scale Synthesis Oligos
Table 5. Key Players of Large-scale Synthesis Oligos
Table 6. Key Players of Linkers and Adaptors
Table 7. Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 8. Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Solid-phase Oligonucleotide Synthesis Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Solid-phase Oligonucleotide Synthesis Market Share by Region (2018-2023)
Table 11. Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Solid-phase Oligonucleotide Synthesis Market Share by Region (2024-2033)
Table 13. Solid-phase Oligonucleotide Synthesis Market Trends
Table 14. Solid-phase Oligonucleotide Synthesis Market Drivers
Table 15. Solid-phase Oligonucleotide Synthesis Market Challenges
Table 16. Solid-phase Oligonucleotide Synthesis Market Restraints
Table 17. Global Solid-phase Oligonucleotide Synthesis Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Solid-phase Oligonucleotide Synthesis Revenue Share by Players (2018-2023)
Table 19. Global Top Solid-phase Oligonucleotide Synthesis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid-phase Oligonucleotide Synthesis as of 2022)
Table 20. Global Solid-phase Oligonucleotide Synthesis Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Solid-phase Oligonucleotide Synthesis Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Solid-phase Oligonucleotide Synthesis, Headquarters and Area Served
Table 23. Global Key Players of Solid-phase Oligonucleotide Synthesis, Product and Application
Table 24. Global Key Players of Solid-phase Oligonucleotide Synthesis, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Solid-phase Oligonucleotide Synthesis Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Type (2018-2023)
Table 28. Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Type (2024-2033)
Table 30. Global Solid-phase Oligonucleotide Synthesis Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Solid-phase Oligonucleotide Synthesis Revenue Share by Application (2018-2023)
Table 32. Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Solid-phase Oligonucleotide Synthesis Revenue Share by Application (2024-2033)
Table 34. North America Solid-phase Oligonucleotide Synthesis Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Solid-phase Oligonucleotide Synthesis Market Size by Type (2024-2033) & (US$ Million)
Table 36. North America Solid-phase Oligonucleotide Synthesis Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Solid-phase Oligonucleotide Synthesis Market Size by Application (2024-2033) & (US$ Million)
Table 38. North America Solid-phase Oligonucleotide Synthesis Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2024-2033) & (US$ Million)
Table 41. Europe Solid-phase Oligonucleotide Synthesis Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Solid-phase Oligonucleotide Synthesis Market Size by Type (2024-2033) & (US$ Million)
Table 43. Europe Solid-phase Oligonucleotide Synthesis Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Solid-phase Oligonucleotide Synthesis Market Size by Application (2024-2033) & (US$ Million)
Table 45. Europe Solid-phase Oligonucleotide Synthesis Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2024-2033) & (US$ Million)
Table 48. China Solid-phase Oligonucleotide Synthesis Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Solid-phase Oligonucleotide Synthesis Market Size by Type (2024-2033) & (US$ Million)
Table 50. China Solid-phase Oligonucleotide Synthesis Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Solid-phase Oligonucleotide Synthesis Market Size by Application (2024-2033) & (US$ Million)
Table 52. Asia Solid-phase Oligonucleotide Synthesis Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Solid-phase Oligonucleotide Synthesis Market Size by Type (2024-2033) & (US$ Million)
Table 54. Asia Solid-phase Oligonucleotide Synthesis Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Solid-phase Oligonucleotide Synthesis Market Size by Application (2024-2033) & (US$ Million)
Table 56. Asia Solid-phase Oligonucleotide Synthesis Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 57. Asia Solid-phase Oligonucleotide Synthesis Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Solid-phase Oligonucleotide Synthesis Market Size by Region (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Type (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Application (2024-2033) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 64. Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2024-2033) & (US$ Million)
Table 66. Genescript Company Details
Table 67. Genescript Business Overview
Table 68. Genescript Solid-phase Oligonucleotide Synthesis Product
Table 69. Genescript Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 70. Genescript Recent Developments
Table 71. GeneArt (Thermofischer) Company Details
Table 72. GeneArt (Thermofischer) Business Overview
Table 73. GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Product
Table 74. GeneArt (Thermofischer) Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 75. GeneArt (Thermofischer) Recent Developments
Table 76. Renesas Electronics Corporation Company Details
Table 77. Renesas Electronics Corporation Business Overview
Table 78. Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Product
Table 79. Renesas Electronics Corporation Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 80. Renesas Electronics Corporation Recent Developments
Table 81. DNA 2.0 (ATUM) Company Details
Table 82. DNA 2.0 (ATUM) Business Overview
Table 83. DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Product
Table 84. DNA 2.0 (ATUM) Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 85. DNA 2.0 (ATUM) Recent Developments
Table 86. OriGene Company Details
Table 87. OriGene Business Overview
Table 88. OriGene Solid-phase Oligonucleotide Synthesis Product
Table 89. OriGene Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 90. OriGene Recent Developments
Table 91. BBI Company Details
Table 92. BBI Business Overview
Table 93. BBI Solid-phase Oligonucleotide Synthesis Product
Table 94. BBI Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 95. BBI Recent Developments
Table 96. Genewiz Company Details
Table 97. Genewiz Business Overview
Table 98. Genewiz Solid-phase Oligonucleotide Synthesis Product
Table 99. Genewiz Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 100. Genewiz Recent Developments
Table 101. Eurofins Genomics Company Details
Table 102. Eurofins Genomics Business Overview
Table 103. Eurofins Genomics Solid-phase Oligonucleotide Synthesis Product
Table 104. Eurofins Genomics Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 105. Eurofins Genomics Recent Developments
Table 106. Gene Oracle Company Details
Table 107. Gene Oracle Business Overview
Table 108. Gene Oracle Solid-phase Oligonucleotide Synthesis Product
Table 109. Gene Oracle Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 110. Gene Oracle Recent Developments
Table 111. SBS Genetech Company Details
Table 112. SBS Genetech Business Overview
Table 113. SBS Genetech Solid-phase Oligonucleotide Synthesis Product
Table 114. SBS Genetech Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 115. SBS Genetech Recent Developments
Table 116. Bio Basic Company Details
Table 117. Bio Basic Business Overview
Table 118. Bio Basic Solid-phase Oligonucleotide Synthesis Product
Table 119. Bio Basic Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 120. Bio Basic Recent Developments
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Solid-phase Oligonucleotide Synthesis Market Share by Type: 2022 VS 2033
Figure 3. Primers Features
Figure 4. Probes Features
Figure 5. Intermediate-scale Synthesis Oligos Features
Figure 6. Large-scale Synthesis Oligos Features
Figure 7. Linkers and Adaptors Features
Figure 8. Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 9. Global Solid-phase Oligonucleotide Synthesis Market Share by Application: 2022 VS 2033
Figure 10. Commercial Case Studies
Figure 11. Academic Research Case Studies
Figure 12. Solid-phase Oligonucleotide Synthesis Report Years Considered
Figure 13. Global Solid-phase Oligonucleotide Synthesis Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Solid-phase Oligonucleotide Synthesis Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Solid-phase Oligonucleotide Synthesis Market Share by Region: 2022 VS 2033
Figure 16. Global Solid-phase Oligonucleotide Synthesis Market Share by Players in 2022
Figure 17. Global Top Solid-phase Oligonucleotide Synthesis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid-phase Oligonucleotide Synthesis as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Solid-phase Oligonucleotide Synthesis Revenue in 2022
Figure 19. North America Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Solid-phase Oligonucleotide Synthesis Market Share by Type (2018-2033)
Figure 21. North America Solid-phase Oligonucleotide Synthesis Market Share by Application (2018-2033)
Figure 22. North America Solid-phase Oligonucleotide Synthesis Market Share by Country (2018-2033)
Figure 23. United States Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Solid-phase Oligonucleotide Synthesis Market Size YoY (2018-2033) & (US$ Million)
Figure 26. Europe Solid-phase Oligonucleotide Synthesis Market Share by Type (2018-2033)
Figure 27. Europe Solid-phase Oligonucleotide Synthesis Market Share by Application (2018-2033)
Figure 28. Europe Solid-phase Oligonucleotide Synthesis Market Share by Country (2018-2033)
Figure 29. Germany Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. China Solid-phase Oligonucleotide Synthesis Market Size YoY (2018-2033) & (US$ Million)
Figure 36. China Solid-phase Oligonucleotide Synthesis Market Share by Type (2018-2033)
Figure 37. China Solid-phase Oligonucleotide Synthesis Market Share by Application (2018-2033)
Figure 38. Asia Solid-phase Oligonucleotide Synthesis Market Size YoY (2018-2033) & (US$ Million)
Figure 39. Asia Solid-phase Oligonucleotide Synthesis Market Share by Type (2018-2033)
Figure 40. Asia Solid-phase Oligonucleotide Synthesis Market Share by Application (2018-2033)
Figure 41. Asia Solid-phase Oligonucleotide Synthesis Market Share by Region (2018-2033)
Figure 42. Japan Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. South Korea Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. China Taiwan Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Southeast Asia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. India Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Australia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size YoY (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Share by Type (2018-2033)
Figure 50. Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Share by Application (2018-2033)
Figure 51. Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Share by Country (2018-2033)
Figure 52. Brazil Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Mexico Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Turkey Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Saudi Arabia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Israel Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. GCC Countries Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Genescript Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 59. GeneArt (Thermofischer) Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 60. Renesas Electronics Corporation Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 61. DNA 2.0 (ATUM) Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 62. OriGene Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 63. BBI Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 64. Genewiz Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 65. Eurofins Genomics Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 66. Gene Oracle Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 67. SBS Genetech Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 68. Bio Basic Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed